🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
SB-751689 may alter calcium and phosphate handling at the kidney level. Thi...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-08
Trial ID
NCT00532077
Treatments Being Tested
The present study aims to evaluate the impact of 5 days oral administration...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-11-02
Trial ID
NCT01802892
Treatments Being Tested
Ronacaleret is an orally administered CaSR antagonist which has previously ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-10-27
Trial ID
NCT01466335
Treatments Being Tested
This study will evaluate the safety, tolerability and exposure of SB-751689...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04
Trial ID
NCT00468689
Treatments Being Tested
This is a 12 month study designed to evaluate the safety and effectiveness ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2007-05-14
Trial ID
NCT00471237
Treatments Being Tested
This study will examine the biological fate of radioactive SB-751689 admini...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04
Trial ID
NCT00499928
Treatments Being Tested
The first purpose of this study is to determine if taking SB-751689 along w...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10
Trial ID
NCT00388596
Treatments Being Tested
This study will examine the effects of altering gastric pH in healthy volun...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07
Trial ID
NCT00508534
Treatments Being Tested
This is a study designed to test the safety and effectiveness of SB-751689 ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2007-09-20
Trial ID
NCT00548496
To investigate the safety and tolerability, PK and PD of SB751689 following...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10-23
Trial ID
NCT00554255
Treatments Being Tested